质子泵抑制剂对铷-82 PET心肌灌注显像胃摄取的影响
该前瞻性研究纳入600例临床行铷-82 PET心肌灌注显像的患者,其中181例(30.2%)使用质子泵抑制剂(PPI)。结果显示PPI使用者胃铷-82摄取较非使用者高23%(146±52 kBq/cc vs 119±40 kBq/cc,P<0.001),胃:肝摄取比值亦高23%(2.7±1.0 vs 2.2±0.8,P<0.001)。提示PPI使用与胃摄取增加相关,可能增加非诊断性图像风险。
要点
- PPI使用者胃铷-82摄取较非使用者高23%,胃:肝比值亦高23%。
- PPI使用可能识别出铷-82 PET MPI非诊断性图像风险更高的患者。
- 胃摄取溢出常影响下壁,可妨碍心肌缺血的准确识别。
核心结论
- 使用PPI的患者铷-82胃摄取更高,可能增加非诊断性铷-82 PET MPI的风险。
研究设计与样本
- 前瞻性纳入600例临床行铷-82 PET MPI的患者,记录PPI使用情况并分为PPI组和非PPI组。
- 在静息状态测量胃、心肌和肝脏的铷-82摄取,比较绝对摄取值和胃:肝比值。
主要发现
- 600例中181例(30.2%)使用PPI。
- PPI使用者胃铷-82摄取为146±52 kBq/cc,非使用者为119±40 kBq/cc,前者高23%(P<0.001)。
- PPI使用者静息胃:肝铷-82摄取比值为2.7±1.0,非使用者为2.2±0.8,前者高23%(P<0.001)。
临床怎么用
- 对使用PPI的患者行铷-82 PET MPI时,应警惕胃摄取增高可能影响图像判读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Rb-82 positron emission tomography (PET) myocardial perfusion imaging (MPI) is a robust tool for the evaluation of coronary artery disease (CAD). However, gastric uptake and spillover can be seen in 10% of Rb-82 PET MPI studies, commonly affecting the inferior wall, and can preclude the accurate identification of myocardial ischemia. We sought to understand the relationship between Rb-82 gastric uptake and the use of proton pump inhibitors (PPI). METHODS: 600 consecutive patients who presented for a clinically indicated Rb-82 PET MPI study were prospectively enrolled. In addition to the clinical history, PPI use was ascertained (medication, dose, frequency and duration of use, and time of last dose). Patients were categorized as PPI and non-PPI users. Rb-82 uptake in the gastrium, myocardium, and liver were measured at rest. Absolute uptake values and gastric:hepatic ratios were compared in PPI and non-PPI users. RESULT: Of 600 enrolled patients, 181 (30.2%) patients were using PPI. The gastric Rb-82 uptake in PPI users was 23% higher than non-PPI users (146 ± 52 kBq/cc vs 119 ± 40 kBq/cc, respectively; P < 0.001). The resting gastric:hepatic Rb-82 uptake ratio was also 23% higher in PPI vs non-PPI users (2.7 ± 1.0 vs 2.2 ± 0.8, respectively; P < 0.001). CONCLUSION: The gastric uptake of Rb-82 appears to be greater in patients actively using PPI and may identify a group who might be at greater risk of non-diagnostic Rb-82 PET MPI.
引用
- Alzahrani AH, Arasaratnam P, Massalha S, et al. Effect of proton pump inhibitors on Rubidium-82 gastric uptake using positron emission tomography myocardial perfusion imaging. J Nucl Cardiol. 2019. PMID: 31768902. doi:10.1007/s12350-019-01954-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。